Results

ChromaDex Corp.

01/25/2022 | Press release | Distributed by Public on 01/25/2022 05:38

ChromaDex Announces Results of New Pilot Clinical Trial Showing Anti-Inflammatory Effects of Nicotinamide Riboside (NR) Supplementation